AbbVie Declares Quarterly Dividend
AbbVie Inc. (NYSE: ABBV) has announced a quarterly cash dividend of $1.55 per share. The dividend will be payable on November 15, 2024, to stockholders of record as of October 15, 2024. Since its inception in 2013, AbbVie has increased its dividend by more than 285 percent. The company is a member of the S&P Dividend Aristocrats Index, which includes companies that have consistently increased their dividends for at least 25 consecutive years.
AbbVie Inc. (NYSE: ABBV) ha annunciato un dividendo trimestrale in contante di $1,55 per azione. Il dividendo sarà pagato il 15 novembre 2024 agli azionisti registrati al 15 ottobre 2024. Dalla sua fondazione nel 2013, AbbVie ha aumentato il suo dividendo di oltre il 285 percento. L'azienda è membro dell'S&P Dividend Aristocrats Index, che include le aziende che hanno costantemente aumentato i loro dividendi per almeno 25 anni consecutivi.
AbbVie Inc. (NYSE: ABBV) ha anunciado un dividendo en efectivo trimestral de $1.55 por acción. El dividendo se pagará el 15 de noviembre de 2024 a los accionistas registrados a partir del 15 de octubre de 2024. Desde su creación en 2013, AbbVie ha aumentado su dividendo en más del 285 por ciento. La compañía es miembro del Índice de Aristócratas del Dividendo S&P, que incluye empresas que han aumentado consistentemente susDividendos durante al menos 25 años consecutivos.
AbbVie Inc. (NYSE: ABBV)는 주당 $1.55의 분기 현금 배당금을 발표했습니다. 배당금은 2024년 11월 15일에 지급되며, 2024년 10월 15일 기준 주주에게 지급됩니다. AbbVie는 2013년 설립 이후 배당금을 285% 이상 증가시켰습니다. 이 회사는 최소 25년 연속으로 배당금을 증가시킨 기업을 포함하는 S&P 배당 귀족 지수의 회원입니다.
AbbVie Inc. (NYSE: ABBV) a annoncé un dividende trimestriel en espèces de 1,55 $ par action. Le dividende sera payable le 15 novembre 2024, aux actionnaires inscrits au 15 octobre 2024. Depuis sa création en 2013, AbbVie a augmenté son dividende de plus de 285 pour cent. L'entreprise est membre de l'Indice des Aristocrates du Dividende S&P, qui comprend les entreprises qui ont régulièrement augmenté leurs dividendes pendant au moins 25 années consécutives.
AbbVie Inc. (NYSE: ABBV) hat eine vierteljährliche Bardividende von 1,55 USD pro Aktie angekündigt. Die Dividende wird am 15. November 2024 an die Aktionäre ausgezahlt, die am 15. Oktober 2024 im Aktienregister stehen. Seit ihrer Gründung im Jahr 2013 hat AbbVie die Dividende um mehr als 285 Prozent erhöht. Das Unternehmen ist Mitglied des S&P Dividend Aristocrats Index, der Unternehmen umfasst, die ihre Dividenden seit mindestens 25 aufeinanderfolgender Jahre konsequent erhöht haben.
- Consistent quarterly dividend payment of $1.55 per share
- 285% increase in dividend since company inception in 2013
- Inclusion in S&P Dividend Aristocrats Index, indicating long-term dividend growth
- None.
The cash dividend is payable November 15, 2024, to stockholders of record at the close of business on October 15, 2024.
Since the company's inception in 2013, AbbVie has increased its dividend by more than 285 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302240676.html
SOURCE AbbVie
FAQ
What is AbbVie's (ABBV) quarterly dividend amount for Q4 2024?
When is the payment date for AbbVie's (ABBV) latest declared dividend?
What is the record date for AbbVie's (ABBV) Q4 2024 dividend?
How much has AbbVie (ABBV) increased its dividend since 2013?
Is AbbVie (ABBV) part of the S&P Dividend Aristocrats Index?
